Fontana JV9 Jul 2019 23:34
As I alluded to this afternoon I was surprised at the lack of buying on the back of the deal.
Here’s a few pointers that I conveniently didn’t post this afternoon as I like to give everyone the same starting time, rather than a few people who happen to read the board mid session.
They are pharmacists who specialise in galenic medicine.
They are specialists in creating medicine with as many natural ingredients as possible.
They can create specific prescriptions for patients that other pharmas who create medicines make with a standard dosage cannot.
This, thus offers a personalised and therefore more effective dosage.
Italian medicine is considered amongst the very best in the world.
Made in Italy as we all know carries such kudos, but q it means more on medicine than it does on clothes or food.
ITALY IS THE LEADING PRODUCER OF MEDICINES IN THE EU, IT HAS JUST SURPASSED GERMANY WITH THE LARGEST INCREASE IN PHARMACEUTICAL EXPORTS.
Ultra tight system linked to the quality and quantity of controls by the Ministry of Health, the Institute of Health, the Italian Medicines Agency, the NAS Carabinieri etc
The Italian System is so valid, so controlled, that the pharmaceutical multinationals that produce drugs in Italy can easily market them abroad, even passing through the strict forks of the American Food & Drug Administration or the British MHRA (Medicine and Healthcare Products Regulatory Agency). Everyone recognizes that if the product is made in Italy it has a series of controls that verify it as safe and valid.
Has distribution deals with 12,000 chemists in Italy. (Those of you who invested in Aphria will know the significance of this..hint price went crazy when it was rumoured Aphria had a deal in place with Canadian pharmacies)
in summary, we have the leading Pharmaceutical Factory in Italy and Europe, a pharmaceutical warehouse, also here in Canosa, an important part that covers 12 thousand square meters in which there is a food sector, a cosmetic and all our logistics, then again, a representative office in Milan, where we also have laboratories and warehouses. In 2015, we started our internationalization by opening a branch in Serbia, in Belgrade, which will also be
the gateway to the countries of Eastern Europe. These are our offices. Source Sergio Fontana CEO
Emmac are on a whole different planet to anything Nuuvera were hoping to ever achieve.
2.6% is amazing for a £15 million mcap who hold a similar amount in the mighty Factom.
Sign In
Follow the stocks
